首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.
【24h】

Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.

机译:分离的大鼠肝细胞对脂溶性胺类药物的吸收和细胞内结合及其对体内代谢清除率的预测意义。

获取原文
获取原文并翻译 | 示例
           

摘要

The hepatic uptake of imipramine and propranolol was investigated after incubation with isolated rat hepatocytes over a wide concentration range (0.04-400 microM). The cell-to-medium concentration ratio (K(p)) was concentration-dependent and could be described using a two-site binding model incorporating a high affinity/low capacity site and a linear component for a site which was apparently not saturated. Maximum (at 0.04 microM) and minimum K(p) values (at 400 microM) were 360 and 280, and 110 and 70 for imipramine and propranolol, respectively. During these incubations, metabolism was inhibited using aminobenzotriazole (an irreversible inhibitor of cytochrome P450). Pretreatment of cells either by freeze-thawing or with saponin (which permeabilizes the plasma membrane) eliminated the saturable process. The saturable uptake process of imipramine was also inhibited by 18 other lipophilic amine drugs (including propranolol). This uptake component may involve membrane transporter(s), whereas the nonsaturable component probably represents partition into the phospholipid component of membranes. Propranolol was further investigated to determine the impact of high K(p) values on hepatocellular clearance. The area under the curve for propranolol concentrations in the total incubate (medium including the cells) from the depletiontime profile was substantially greater than the corresponding area under the curve for the drug concentration in the extracellular medium, and this difference approximated the nonsaturable uptake component. It is concluded that the clearance of propranolol in isolated hepatocytes is not rate-limited by hepatic uptake and is directly proportional to unbound drug concentration, being independent of the higher K(p) value.
机译:与分离的大鼠肝细胞在宽浓度范围(0.04-400 microM)孵育后,研究了丙咪嗪和普萘洛尔的肝吸收。细胞与培养基的浓度比(K(p))是浓度依赖性的,可以使用包含高亲和力/低容量位点和线性成分的两点结合模型来描述,该位点显然不饱和。最大值(0.04 microM)和最小值K(p)值(400 microM)分别为imipramine和普萘洛尔,分别为360和280,以及110和70。在这些孵育过程中,使用氨基苯并三唑(细胞色素P450的不可逆抑制剂)抑制了新陈代谢。通过冷冻-解冻或用皂苷(透化质膜)对细胞进行预处理可消除可饱和过程。丙咪嗪的饱和摄取过程也被其他18种亲脂胺药物(包括普萘洛尔)抑制。该摄取组分可能涉及膜转运蛋白,而不饱和组分可能代表分配进入膜的磷脂组分。进一步研究了普萘洛尔以确定高K(p)值对肝细胞清除率的影响。根据耗竭时间曲线,在总孵育液(包括细胞在内的培养基)中,普萘洛尔浓度曲线下的面积显着大于细胞外培养基中药物浓度曲线下的相应面积,该差异近似于不饱和摄取成分。结论是,分离的肝细胞中普萘洛尔的清除率不受肝脏摄取速率的限制,并且与未结合的药物浓度成正比,与较高的K(p)值无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号